Table 2.

Cancer screening rates by patient–provider gender concordance

Breast cancer screeningCervical cancer screeningColorectal cancer screening
YesNoYesNoYesNo
N (%)N (%)N (%)N (%)N (%)N (%)
All patients
 Gender concordant2,103 (60.2)1,390 (39.8)b3,681 (61.9)2,269 (38.1)b4,345 (55.3)3,516 (44.7)b
 Gender discordant5,003 (55.2)4,065 (44.8)8,685 (57.3)6,465 (42.7)3,612 (50.0)3,618 (50.0)
Stratified by race/ethnicity
 Black patients
  Gender concordant408 (62.0)250 (38.0)a433 (71.3)174 (28.7)b590 (56.0)465 (44.0)a
  Gender discordant831 (56.0)653 (44.0)726 (64.6)397 (35.4)601 (51.4)569 (48.6)
 White patients
  Gender concordant1,390 (60.2)920 (39.8)b1,317 (67.0)648 (33.0)b3,291 (57.3)2,457 (42.7)b
  Gender discordant3,449 (56.1)2,703 (43.9)2,653 (62.4)1,600 (37.6)2,610 (51.9)2,423 (48.1)
 Hispanic patients
  Gender concordant305 (58.1)220 (41.9)a403 (66.2)209 (33.8)464 (43.9)594 (56.1)a
  Gender discordant723 (50.5)709 (49.5)934 (62.3)564 (37.7)401 (39.0)626 (61.0)
Stratified by insurance status
 Private insurance
  Gender concordant1,578 (64.2)879 (35.8)b1,755 (70.0)752 (30.0)b3,291 (57.8)2,406 (42.2)b
  Gender discordant3,682 (60.5)2,400 (39.5)3,398 (66.2)1,735 (33.8)2,554 (54.2)2,212 (45.8)
 Public insurance
  Gender concordant431 (52.8)385 (47.2)b252 (63.0)148 (37.0)955 (53.5)829 (46.5)b
  Gender discordant1,126 (46.4)1,302 (53.6)579 (58.2)415 (41.8)959 (45.5)1,147 (54.5)
 Uninsured
  Gender concordant94 (42.7)126 (57.3)a146 (52.7)131 (47.3)a99 (26.1)281 (73.9)
  Gender discordant195 (34.9)363 (65.1)336 (45.0)411 (55.0)99 (27.7)259 (72.3)